Patents by Inventor Marcus Stark

Marcus Stark has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANGIOTENSIN II RECEPTOR ANTAGONIST FOR THE PREVENTION OR TREATMENT OF SYSTEMIC DISEASES IN CATS
    Publication number: 20210106564
    Abstract: A method is described for the prophylaxis or treatment of hypertension in a cat in need of such treatment. The method includes administration of a therapeutically effective amount of angiotensin II receptor 1 (AT-1) antagonist (sartan) to the cat, where the therapeutically effective amount of the sartan is administered in a daily dosage amount that is varied over a treatment period, the daily dosage amount of the sartan for a first period of time during the treatment period is 1.0 to 5.0 mg/kg of body weight, and the daily dosage amount of the sartan is decreased for a second period of time subsequent the first period of time during the treatment period.
    Type: Application
    Filed: December 22, 2020
    Publication date: April 15, 2021
    Inventors: Balazs ALBRECHT, Sven ANKE, Saskia KLEY, Stefan Johannes LEHNER, Marcus STARK, Anne Michelle TRAAS, Tanja Margrit ZIMMERING
  • Angiotensin II receptor antagonist for the prevention or treatment of systemic diseases in cats
    Patent number: 10357479
    Abstract: A method is described for the treatment of systemic diseases in cats. A composition is administered to a cat, where the composition includes a therapeutically effective amount of angiotensin II receptor 1 (AT-1) antagonist (sartan).
    Type: Grant
    Filed: March 8, 2018
    Date of Patent: July 23, 2019
    Assignee: BOEHRINGER INGELHEIM VETMEDICA GMBH
    Inventors: Marcus Stark, Ulrike D. Sent, Ingo Lang
  • ANGIOTENSIN II RECEPTOR ANTAGONIST FOR THE PREVENTION OR TREATMENT OF SYSTEMIC DISEASES IN CATS
    Publication number: 20190008831
    Abstract: A method is described for the prophylaxis or treatment of hypertension in a cat in need of such treatment. The method includes administration of a therapeutically effective amount of angiotensin II receptor 1 (AT-1) antagonist (sartan) to the cat, where the therapeutically effective amount of the sartan is administered in a daily dosage amount that is varied over a treatment period, the daily dosage amount of the sartan for a first period of time during the treatment period is 1.0 to 5.0 mg/kg of body weight, and the daily dosage amount of the sartan is decreased for a second period of time subsequent the first period of time during the treatment period.
    Type: Application
    Filed: July 5, 2018
    Publication date: January 10, 2019
    Inventors: Balazs ALBRECHT, Sven ANKE, Saskia KLEY, Stefan Johannes LEHNER, Marcus STARK, Anne Michelle TRAAS, Tanja Margrit ZIMMERING
  • Angiotensin II Receptor Antagonist for the Prevention or Treatment of Systemic Diseases in Cats
    Publication number: 20180193317
    Abstract: A method is described for the treatment of systemic diseases in cats. A composition is administered to a cat, where the composition includes a therapeutically effective amount of angiotensin II receptor 1 (AT-1) antagonist (sartan).
    Type: Application
    Filed: March 8, 2018
    Publication date: July 12, 2018
    Inventors: Marcus Stark, Ulrike D. Sent, Ingo Lang
  • Angiotensin II receptor antagonist for the prevention or treatment of systemic diseases in cats
    Patent number: 9949954
    Abstract: A method is described for the treatment of systemic diseases in cats. A composition is administered to a cat, where the composition includes a therapeutically effective amount of angiotensin II receptor 1 (AT-1) antagonist (sartan).
    Type: Grant
    Filed: January 20, 2017
    Date of Patent: April 24, 2018
    Assignee: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Marcus Stark, Ulrike D. Sent, Ingo Lang
  • Angiotensin II Receptor Antagonist for the Prevention or Treatment of Systemic Diseases in Cats
    Publication number: 20170128423
    Abstract: A method is described for the treatment of systemic diseases in cats. A composition is administered to a cat, where the composition includes a therapeutically effective amount of angiotensin II receptor 1 (AT-1) antagonist (sartan).
    Type: Application
    Filed: January 20, 2017
    Publication date: May 11, 2017
    Inventors: Marcus Stark, Ulrike D. Sent, Ingo Lang
  • Angiotensin II receptor antagonist for the prevention or treatment of systemic diseases in cats
    Patent number: 9585873
    Abstract: A method is described for the treatment of systemic diseases in cats. A composition is administered to a cat, where the composition includes a therapeutically effective amount of angiotensin II receptor 1 (AT-1) antagonist (sartan).
    Type: Grant
    Filed: June 2, 2014
    Date of Patent: March 7, 2017
    Assignee: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Marcus Stark, Ulrike D. Sent, Ingo Lang
  • Angiotensin II receptor antagonist for the prevention or treatment of systemic diseases in cats
    Patent number: 9308197
    Abstract: A pharmaceutical composition for prophylaxis or treatment of systemic diseases in cats, wherein the composition comprising administration of a therapeutically effective amount of angiotensin II receptor 1 (AT-1) antagonist (sartan) to a cat in need of such a treatment.
    Type: Grant
    Filed: March 13, 2013
    Date of Patent: April 12, 2016
    Assignee: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Marcus Stark, Ulrike D Sent, Ingo Lang
  • Angiotensin II Receptor Antagonist for the Prevention or Treatment of Systemic Diseases in Cats
    Publication number: 20140288138
    Abstract: A method is described for the treatment of systemic diseases in cats. A composition is administered to a cat, where the composition includes a therapeutically effective amount of angiotensin II receptor 1 (AT-1) antagonist (sartan).
    Type: Application
    Filed: June 2, 2014
    Publication date: September 25, 2014
    Applicant: BOEHRINGER INGELHEIM VETMEDICA GMBH
    Inventors: Marcus Stark, Ulrike D. Sent, Ingo Lang
  • Angiotensin II receptor antagonist for the prevention or treatment of systemic diseases in cats
    Patent number: 8772278
    Abstract: The present invention relates to a method of prophylaxis or treatment of systemic diseases in cats, wherein the method comprising administration of a therapeutically effective amount of angiotensin II receptor 1 (AT-1) antagonist (sartan) to a cat in need of such a treatment.
    Type: Grant
    Filed: October 5, 2007
    Date of Patent: July 8, 2014
    Assignee: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Marcus Stark, Ulrike Sent, Ingo Lang
  • Angiotensin II receptor antagonist for the prevention or treatment of systemic diseases in cats
    Publication number: 20080146543
    Abstract: The present invention relates to a method of prophylaxis or treatment of systemic diseases in cats, wherein the method comprising administration of a therapeutically effective amount of angiotensin II receptor 1 (AT-1) antagonist (sartan) to a cat in need of such a treatment.
    Type: Application
    Filed: October 5, 2007
    Publication date: June 19, 2008
    Applicant: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Marcus Stark, Ulrike Sent, Ingo Lang
  • METHOD FOR IMPROVING DIAGNOSTIC QUALITY IN ECHOCARDIOGRAPHY
    Publication number: 20070054838
    Abstract: The present invention provides a method for improving diagnostic quality in echocardiography, especially for patients having an elevated heart rate.
    Type: Application
    Filed: September 6, 2006
    Publication date: March 8, 2007
    Inventors: Marcus Stark, Rainer Kleemann, Juergen Daemmgen